Literature DB >> 2253655

Mephenytoin stereoselective elimination in the rat: III. Stereoselective time course of induction during chronic hepatic portal vein administration.

S H Akrawi1, P J Wedlund.   

Abstract

The blood concentrations of R- and S-mephenytoin were followed in seven rats over a 5-8 day period during a hepatic portal vein infusion of racemic mephenytoin. In all but two rats, both of the enantiomers achieved an initial steady-state level before a measurable change was observed in their blood concentrations. In each case, the decrease in the initial S-mephenytoin steady state blood level occurred after the change in R-mephenytoin was apparent. During the period of study, the mean +/- SD portal vein clearance of S-mephenytoin increased from 96 +/- 33 ml/h to 450 +/- 160 ml/h. The mean +/- SD portal vein clearance of R-mephenytoin increased from 170 +/- 50 ml/h to 2400 +/- 1600 ml/h. The larger increase in the portal vein clearance for the R-enantiomer resulted in the R/S-mephenytoin clearance ratio over this same time period changing from 1.8 +/- 0.2 to 5.2 +/- 1.8. Attempts to describe the time course of change in the clearance of S- or R-mephenytoin using a previously reported model of induction were unsuccessful. The induction time course did suggest, however, that the rate of induction may be similar for each enantiomer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253655     DOI: 10.1007/BF03190211

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  30 in total

1.  Time-dependent kinetics. VI: Direct relationship between equations for drug levels during induction and those involving constant clearance.

Authors:  R H Levy; M S Dumain
Journal:  J Pharm Sci       Date:  1979-07       Impact factor: 3.534

2.  Time-dependent kinetics. V: Time course of drug levels during enzyme induction (one-compartment model).

Authors:  R H Levy; M S Dumain; J L Cook
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

3.  Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone.

Authors:  S Toon; W F Trager
Journal:  J Pharm Sci       Date:  1984-11       Impact factor: 3.534

4.  Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration.

Authors:  S H Akrawi; P J Wedlund
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Oct-Dec       Impact factor: 2.441

5.  Induction of drug-metabolizing enzymes by the enantiomers of normephenytoin in the rat.

Authors:  R James; A Küpfer; J P Villeneuve; R A Branch
Journal:  Drug Metab Dispos       Date:  1981 May-Jun       Impact factor: 3.922

6.  Correlation of apparent intrinsic clearances of simultaneously administered S (+) and d3R (-) hexobarbital in the rat.

Authors:  M van der Graaff; N P Vermeulen; P H Hofman; D D Breimer
Journal:  Biochem Pharmacol       Date:  1987-04-15       Impact factor: 5.858

7.  Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.

Authors:  P J Wedlund; B J Sweetman; C B McAllister; R A Branch; G R Wilkinson
Journal:  J Chromatogr       Date:  1984-04-13

8.  Method for chronic portal vein infusion in unrestrained rats.

Authors:  S H Akrawi; P J Wedlund
Journal:  J Pharmacol Methods       Date:  1987-03

9.  Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.

Authors:  W Schmidt; D Trenk; E Jähnchen
Journal:  Pharmacology       Date:  1980       Impact factor: 2.547

10.  Kinetics of misonidazole enantiomers.

Authors:  K M Williams
Journal:  Clin Pharmacol Ther       Date:  1984-12       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.